These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2193835)

  • 1. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome.
    Caruso I; Sarzi Puttini P; Cazzola M; Azzolini V
    J Int Med Res; 1990; 18(3):201-9. PubMed ID: 2193835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin precursors in chronic primary headache. A double-blind cross-over study with L-5-hydroxytryptophan vs. placebo.
    De Benedittis G; Massei R
    J Neurosurg Sci; 1985; 29(3):239-48. PubMed ID: 3913752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study.
    Sarzi Puttini P; Caruso I
    J Int Med Res; 1992 Apr; 20(2):182-9. PubMed ID: 1521674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of essential headache in developmental age with L-5-HTP (cross over double-blind study versus placebo)].
    Longo G; Rudoi I; Iannuccelli M; Strinati R; Panizon F
    Pediatr Med Chir; 1984; 6(2):241-5. PubMed ID: 6397729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome.
    Caruso I; Sarzi Puttini PC; Boccassini L; Santandrea S; Locati M; Volpato R; Montrone F; Benvenuti C; Beretta A
    J Int Med Res; 1987; 15(3):154-9. PubMed ID: 3301454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and polygraphic effects of d.1 5 HTP on narcolepsy-cataplexy.
    Autret A; Minz M; Beillevaire T; Degos C; Cathala HP
    Biomedicine; 1977 Jul; 27(5):200-3. PubMed ID: 336110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study.
    Angst J; Woggon B; Schoepf J
    Arch Psychiatr Nervenkr (1970); 1977 Oct; 224(2):175-86. PubMed ID: 336002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.
    Crofford LJ; Rowbotham MC; Mease PJ; Russell IJ; Dworkin RH; Corbin AE; Young JP; LaMoreaux LK; Martin SA; Sharma U;
    Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society.
    Ribeiro CA
    Headache; 2000 Jun; 40(6):451-6. PubMed ID: 10849040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study.
    Moldofsky H; Harris HW; Archambault WT; Kwong T; Lederman S
    J Rheumatol; 2011 Dec; 38(12):2653-63. PubMed ID: 21885490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy.
    Nicolodi M; Sicuteri F
    Adv Exp Med Biol; 1996; 398():373-9. PubMed ID: 8906292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibromyalgia and the serotonin pathway.
    Juhl JH
    Altern Med Rev; 1998 Oct; 3(5):367-75. PubMed ID: 9802912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
    Younger J; Noor N; McCue R; Mackey S
    Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Headache in association with sleep disorders in children: a psychodiagnostic evaluation and controlled clinical study--L-5-HTP versus placebo.
    De Giorgis G; Miletto R; Iannuccelli M; Camuffo M; Scerni S
    Drugs Exp Clin Res; 1987; 13(7):425-33. PubMed ID: 3308389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin.
    Arnold LM; Zlateva G; Sadosky A; Emir B; Whalen E
    Pain Med; 2011 Feb; 12(2):260-7. PubMed ID: 21266008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study.
    Aliño JJ; Gutierrez JL; Iglesias ML
    Int Pharmacopsychiatry; 1976; 11(1):8-15. PubMed ID: 770365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ; Myers RR
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind clinical trial of 5-hydroxytryptophan in a case of Lesch-Nyhan syndrome.
    Frith CD; Johnston EC; Joseph MH; Powell RJ; Watts RW
    J Neurol Neurosurg Psychiatry; 1976 Jul; 39(7):656-62. PubMed ID: 792398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.
    Turner EH; Loftis JM; Blackwell AD
    Pharmacol Ther; 2006 Mar; 109(3):325-38. PubMed ID: 16023217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotropic treatment of chronic fatigue syndrome and related disorders.
    Goodnick PJ; Sandoval R
    J Clin Psychiatry; 1993 Jan; 54(1):13-20. PubMed ID: 8428892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.